Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Proceedings of the National Academy of Sciences of the United States of America
Sandrine BelouzardGary R Whittaker


The coronavirus spike protein (S) plays a key role in the early steps of viral infection, with the S1 domain responsible for receptor binding and the S2 domain mediating membrane fusion. In some cases, the S protein is proteolytically cleaved at the S1-S2 boundary. In the case of the severe acute respiratory syndrome coronavirus (SARS-CoV), it has been shown that virus entry requires the endosomal protease cathepsin L; however, it was also found that infection of SARS-CoV could be strongly induced by trypsin treatment. Overall, in terms of how cleavage might activate membrane fusion, proteolytic processing of the SARS-CoV S protein remains unclear. Here, we identify a proteolytic cleavage site within the SARS-CoV S2 domain (S2', R797). Mutation of R797 specifically inhibited trypsin-dependent fusion in both cell-cell fusion and pseudovirion entry assays. We also introduced a furin cleavage site at both the S2' cleavage site within S2 793-KPTKR-797 (S2'), as well as at the junction of S1 and S2. Introduction of a furin cleavage site at the S2' position allowed trypsin-independent cell-cell fusion, which was strongly increased by the presence of a second furin cleavage site at the S1-S2 position. Taken together, these data sugges...Continue Reading


Feb 1, 1994·Trends in Microbiology·H D Klenk, W Garten
May 31, 1993·Annals of the New York Academy of Sciences·N G SeidahM Chrétien
Aug 9, 2001·Proceedings of the National Academy of Sciences of the United States of America·L González-ReyesJ A Melero
Mar 5, 2003·The Journal of Experimental Medicine·Birke BartoschFrançois-Loïc Cosset
Apr 3, 2003·Nature Reviews. Molecular Cell Biology·Peter M Colman, Michael C Lawrence
Dec 4, 2003·Biochemical and Biophysical Research Communications·Xiaodong XiaoDimiter S Dimitrov
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Graham SimmonsPaul Bates
Jun 15, 2004·The Journal of Infectious Diseases·Yong Xiu YaoIan M Jones
Dec 15, 2004·Biochemical and Biophysical Research Communications·Eric BergeronNabil G Seidah
Apr 16, 2005·Science·Kartik ChandranJames M Cunningham
Aug 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Graham SimmonsPaul Bates
Aug 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shutoku MatsuyamaFumihiro Taguchi
Oct 29, 2005·Journal of Virology·Cornelis A M de HaanPeter J M Rottier
Dec 13, 2005·The Journal of Biological Chemistry·I-Chueh HuangHyeryun Choe
Mar 31, 2006·Journal of Virology·Kathryn SchornbergJudith White
Oct 14, 2006·Advances in Experimental Medicine and Biology·Graham SimmonsPaul Bates
Feb 14, 2007·Veterinary Research·Dave Cavanagh
May 30, 2007·Biochemical and Biophysical Research Communications·Lanying DuBo-Jian Zheng
Sep 18, 2007·Current Opinion in Structural Biology·Robert A Lamb, Theodore S Jardetzky
Oct 12, 2007·Journal of Virology·Rachel L KaletskyPaul Bates
Nov 27, 2007·FEBS Letters·A PasquatoC Di Bello
Mar 18, 2008·The International Journal of Biochemistry & Cell Biology·Nabil G SeidahAnnik Prat
Jun 24, 2008·Critical Reviews in Biochemistry and Molecular Biology·Judith M WhiteKathryn Schornberg
Jul 4, 2008·Nature Structural & Molecular Biology·Stephen C Harrison
Jul 11, 2008·Nature·Jeffrey E LeeErica Ollmann Saphire

❮ Previous
Next ❯


May 27, 2011·Journal of Virology·Kazuya ShiratoFumihiro Taguchi
Jan 12, 2013·Current Protein & Peptide Science·Natasa Kopitar-Jerala
Jul 21, 2012·Viruses·Sandrine BelouzardGary R Whittaker
Mar 24, 2012·Current Opinion in Virology·Denis Gerlier
Mar 5, 2016·Traffic·Judith M White, Gary R Whittaker
Dec 3, 2014·Virus Research·Jean Kaoru Millet, Gary R Whittaker
Oct 27, 2009·Journal of Molecular Biology·Ying GuoMichael Caffrey
Oct 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jean Kaoru Millet, Gary R Whittaker
Nov 7, 2014·PLoS Pathogens·Christine BurkardCornelis A M de Haan
May 24, 2016·Virus Research·Samaporn TeeravechyanAnan Jongkaewwattana
Jun 19, 2016·Virus Research·Wentao LiBerend-Jan Bosch
Jul 19, 2016·Antiviral Research·Jean K MilletSandrine Belouzard
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jung-Eun ParkTom Gallagher
Sep 1, 2016·Annual Review of Virology·Fang Li
Nov 13, 2013·The Journal of Infectious Diseases·David S Hui, Alimuddin Zumla
Dec 22, 2016·Emerging Microbes & Infections·Jean Kaoru MilletGary R Whittaker
Oct 27, 2017·Proceedings of the National Academy of Sciences of the United States of America·Alexandra C WallsDavid Veesler

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.